AXTI vs TECH · rev $99.4M vs P/E 65, rev $1.22B
AXT Inc (AXTI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
AXT Inc (AXTI) is a semiconductor equipment & materials company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AXTI revenue for 2024-12-31 was $99.4M. Net income was -$11.8M. Revenue was up 386.4% from 2023-12-31 to 2024-12-31. AXTI currently screens at market cap $6.75B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AXTI currently screens at market cap $6.75B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AXTI and TECH stock pages for the full models.
Not investment advice.